LDOS vs STRO
Leidos Holdings Inc (LDOS) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported LDOS revenue for 2025-01-03 was $16.66B. Net income was $1.25B. Revenue was up 7.9% from 2023-12-29 to 2025-01-03. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
LDOS currently screens at market cap $20.04B and trailing P/E 15.7. STRO currently screens at market cap $470.8M.
Not investment advice. Open the LDOS and STRO stock pages for the full models.
Not investment advice.